Bivision
About:
Bivision is a biomedical enterprise focusing on the research and development of targeted radiopharmaceuticals (TRT).
Website: http://www.bivisionpharma.com/
Top Investors: Gaorong Capital, Kaitai Capital, Yijing Capital, Huajin Capital, Tigermed
Description:
Biovision Pharma is a biomedical enterprise focusing on the research and development of targeted radiopharmaceuticals (TRT) integrated with visual diagnosis and treatment.
Total Funding Amount:
200M CNY
Headquarters Location:
Shanghai, Shanghai, China
Founded Date:
2021-01-01
Contact Email:
info(AT)bivisionpharma.com
Founders:
Number of Employees:
11-50
Last Funding Date:
2024-07-26
IPO Status:
Private
Industries:
© 2025 bioDAO.ai